Childhood Cancer Clinical Trials Act

The Childhood Cancer Clinical Trials Act, also known as Bill 118 hr 5647, is a piece of legislation that aims to improve access to clinical trials for children with cancer. The bill was introduced in the US Congress with the goal of increasing the number of children who are able to participate in clinical trials for cancer treatments.

One of the key provisions of the bill is the establishment of a national childhood cancer registry, which would help to track the outcomes of children who participate in clinical trials. This registry would provide valuable data on the effectiveness of different treatments and help to identify areas where more research is needed.

Additionally, the bill includes provisions to increase funding for childhood cancer research and to improve coordination between different agencies and organizations involved in cancer research. This would help to ensure that resources are being used efficiently and that research efforts are focused on the most promising treatments. Overall, the Childhood Cancer Clinical Trials Act is aimed at improving outcomes for children with cancer by increasing access to cutting-edge treatments and improving the coordination of research efforts. It has received bipartisan support in Congress and is seen as a positive step towards improving the care and outcomes for children with cancer.